Cargando…
Rituximab induced cytokine release syndrome in an MS patient: A case report
Cytokine release syndrome with rituximab has been reported in certain diseases, however, it is rarely reported in MS patients treated with rituximab. The treating physician should suspect the syndrome when typical signs and symptoms appear.
Autores principales: | Etemadifar, Masoud, Salari, Mehri, Saeri, Mahdieh, Sigari, Amirhossein Akhavan, Ebrahimi Pelarti, Sara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8271264/ https://www.ncbi.nlm.nih.gov/pubmed/34267900 http://dx.doi.org/10.1002/ccr3.4407 |
Ejemplares similares
-
Myasthenia gravis and coronavirus disease 2019: A report from Iran
por: Etemadifar, Masoud, et al.
Publicado: (2021) -
Complete horizontal gaze palsy due to bilateral paramedian pontine reticular formation involvement as a presentation of multiple sclerosis: a case report
por: Akhavan Sigari, Amirhossein, et al.
Publicado: (2019) -
Outcome of COVID-19 infection in multiple sclerosis patients receiving disease-modifying therapies
por: Etemadifar, Masoud, et al.
Publicado: (2021) -
Self-Reported safety of the BBIBP-CorV (Sinopharm) COVID-19 vaccine among Iranian people with multiple sclerosis
por: Etemadifar, Masoud, et al.
Publicado: (2022) -
Efficacy and safety of rituximab in neuromyelitis optica: Review of evidence
por: Etemadifar, Masoud, et al.
Publicado: (2017)